lood pressure (BP) has been reported to be directly related to mortality from vascular disease down to at least 115/75 mm Hg with no clear threshold level.
B
lood pressure (BP) has been reported to be directly related to mortality from vascular disease down to at least 115/75 mm Hg with no clear threshold level. 1 Evidence from previous research suggests that low BP is a predictor of mortality in various clinical settings, and J-or U-curve associations between BP and vascular mortality have been reported among the elderly and those with vascular or other diseases. [2] [3] [4] [5] [6] [7] [8] [9] Low BP, even a single incidence of isolated hypotensive BP in certain situations, can predict mortality, 10 but despite the evidence, physicians often ignore low BP. 10, 11 There is no doubt, however, that a J-curve association between BP and mortality exists, even in the general population with no known comorbid diseases, because adequate perfusion to vital organs is difficult to sustain below a certain BP. In nonclinical populations, a few studies have found that low BP was associated with a higher mortality from vascular disease. [12] [13] [14] However, it is unclear whether and in what range of BP a J-curve occurs. We conducted a large prospective cohort study with >1 million participants to demonstrate whether a J-curve association exists between systolic BP (SBP) and mortality from vascular disease in a nonclinical population. We focused on SBP, because SBP has been shown to be a better predictor of mortality from vascular disease than diastolic BP (DBP) or pulse pressure in prospective studies among the general population. . The SBP category with the lowest vascular risk was used as the referent group. χ 2 tests and 1-way analysis of variance were performed to compare the differences between SBP groups.
Statistical Analysis
Cox proportional hazards models were used to evaluate the association between SBP at baseline and mortality, and the analyses were adjusted for the following covariates: age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/d; 0, 1-20, >20); physical activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m 2 ; continuous). The HRs of restricted cubic spline transformation of continuous confounders with 3 knots (5th, 50th, and 95th percentiles) with death from atherosclerotic vascular disease were plotted ( Figure I in the online-only Data Supplement). DBP was adjusted for as a continuous variable by using restricted cubic splines with 5 knots (50, 60, 70, 80, and 90 mm Hg) to examine whether the effects of SBP are independent of those of DBP. HRs of restricted cubic spline transformation of SBP with 5 knots (80, 90, 100, 110, and 120 mm Hg) and 90 mm Hg as a reference were also plotted. The nonlinear associations of SBP with vascular mortality were assessed with a likelihood ratio test, in which we compared the model with only the linear term with the model with both the linear and the cubic spline terms.
A stratified analysis was performed according to age at entry (≥60 or <60 years) to examine whether association varied according to age group. 1, 13, 21 Sex-stratified analysis was also done. In additional analyses, we excluded all deaths (n=23 372) that had occurred in the first 5 years of follow-up. 12 These analyses ensured sensitivity in our results. The interaction of age or sex with SBP on mortality was assessed by including an interaction term (age × SBP or sex × SBP) in the analysis stratified by SBP (<100 or ≥100 mm Hg), assuming a linear inverse association at <100 mm Hg and a linear positive association at ≥100 mm Hg. Proportional assumption was tested by using Schoenfeld residuals. The survival curve according to SBP was plotted using the life-table method ( Figure II in the online-only Data Supplement).
Two-sided P values were calculated, and the statistical significance level was set at 0.05. All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC).
Results
A total of 154 882 deaths (crude death rate, 683 deaths per 100 000 person-years) occurred during 22 674 299 personyears (mean, 18.4 person-years) of follow-up, and of these, 34 816 died of atherosclerotic vascular diseases (154 deaths per 100 000 person-years). At enrollment, the mean (standard deviation) age was 46.6 (11.6) years, and the mean SBP was 123.4 (17.2) mm Hg (Table 1) . Participants with SBP <90 mm Hg tended to be women and had the lowest levels of DBP, total cholesterol, fasting glucose, and BMI of all SBP groups. They were also older than those with SBPs of 90 to 139 mm Hg (Table II in the online-only Data Supplement). The proportion of current smokers and current drinkers was highest in individuals with SBPs of 120 to 139 mm Hg.
Both low and high SBPs were associated with higher atherosclerotic vascular mortality (Figures 1 and 2 ), and the lowest atherosclerotic vascular mortality was associated with an SBP of 90 to 109 mm Hg, which rose thereafter as the SBP increased; the mortality was also higher in those with an SBP <90 mm Hg (hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.15-2.03; Table 2 ). The HR associated with an SBP below 90 mm Hg, in comparison with 90 to 99 mm Hg, was 2.54 (95% CI, 1.51-4.29) for ischemic heart disease, and 1.21 (95% CI, 0.79-1.86) for stroke. Among stroke subtypes, the HR associated with an SBP <90 mm Hg was 1.64 for hemorrhagic stroke mortality and 0.76 for ischemic stroke mortality.
After exclusion of the first 5 years of follow-up, the association between the lowest SBP group and vascular mortality did not weaken ( Figure III in the online-only Data Supplement). When DBP (restricted cubic splines with 5 knots at 50, 60, 70, 80, and 90 mm Hg), and restricted cubic splines of continuous confounders (age, total cholesterol, BMI, and fasting glucose) with 3 knots at the 5th, 50th, and 95th percentile of each variable were added, the observed associations with low SBP were generally unchanged ( Figure IV in the online-only Data Supplement).
When stratified by age group, higher HRs associated with the lowest SBP for atherosclerotic vascular mortality and ischemic heart disease in comparison with the reference
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were statistically significant in older participants aged 60 to 95 years, but not in younger participants aged 30 to 59 years ( Figure 3 , Figures V and VI in the online-only Data Supplement, Table III in the online-only Data Supplement). In addition, in stratified analyses by SBP assuming linear associations (Tables IV through VI in Table V in the online-only Data Supplement). However, when interactions between age and SBP were evaluated by using interaction terms of age and SBP, the P value was >0.05 for each type of vascular mortality given an SBP <100 mm Hg. In individuals aged 60 to 95 years, and in those aged 30 to 59 years, as well, vascular mortality increased as SBP increased to >90 to 99 mm Hg, and the association between high SBP and vascular mortality was greater among individuals <60 years than it was among those aged 60 to 95 years. The P values for the linear interaction between age and SBP were <0.001 for vascular mortality given an SBP of 100 to 290 mm Hg. In analyses stratified by sex, the HRs associated with the lowest SBP for atherosclerotic vascular diseases were 1.63 (95% CI, 1.13-2.34) in women and 1.37 (95% CI, 0.87-2.14) in men (Figures VII through IX in the online-only Data Supplement, Table VII in the online-only Data Supplement). However, P values of linear interaction between men and women in the range <100 mm Hg were generally >0.05 (Table  VI in the online-only Data Supplement).
We tested the proportional assumption and found no evidence of a violation of the proportional assumption for the dummy variable of SBP <90 mm Hg for any cause of vascular mortality. However, evidence indicated that several variables including several dummy SBP variables may have nonproportional HRs over the follow-up time period. For such variables, analysis was done by stratifying according to the variables (not dummy SBP variables such as alcohol consumption and exercise). In addition, time-dependent covariables for dummy SBP variables (which were generated using the Model Statement of the PROC PHREG procedure) were included to address nonproportionality. 22 In addition, we analyzed individuals who survived as of January 1, 2003 to examine whether the association of SBP in 2003 to 2012 was different from that during the entire follow-up period (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . The associations with low SBP were unchanged (Figure X in the online-only Data Supplement).
Discussion
Investigation of a healthy Korean population without known preexisting illnesses exhibited J-curve associations between SBP and death from atherosclerotic vascular diseases, with a nadir at 90 to 109 mm Hg for vascular mortality. An SBP <90 mm Hg was associated with ≈50% higher mortality from atherosclerotic vascular disease, especially ischemic heart disease (≈150% higher mortality), in comparison with an SBP of 90 to 99 mm Hg.
Association Between Low SBP and Vascular Mortality
This study revealed that SBPs <90 mm Hg are related to an increased risk of vascular mortality. The majority of previous reports on the J-curve association between BP and vascular mortality studied clinical patients with vascular disease, [2] [3] [4] [5] [6] 9, 23 and, although similar findings have been reported in Korean nonclinical populations, those results are limited by a small number of deaths in the lowest SBP categories and the selfreported nature of BP measurements. 13, 14 The current study clearly showed that J-curve associations exist between SBP and vascular mortality, especially mortality from ischemic heart disease, in Korean adults. However, these associations do not guarantee a causal relationship. It is possible that a low SBP could be a consequence of concurrent frailty or chronic disease, even though the participants in our study constituted a nonclinical population with no known preexisting diseases, such as cancer, heart disease, or stroke. Furthermore, the population of the current study was generally healthier than the average Korean population. 17 Because individuals with underlying conditions who have a low SBP, even if undiagnosed at the time of study entry, may die prematurely, we additionally excluded patients who died during the first 5 years of follow-up. After such exclusion, the relative risk of mortality associated with low SBP increased, albeit modestly, relative to those of the main analysis. Therefore, reverse causality may not be solely responsible for the association between low SBP and death from vascular disease. However, because a comprehensive cardiovascular evaluation was not conducted for each participant, the possibility of some of the participants with the lowest SBP having undiagnosed cardiovascular disease and taking BP-lowering medications cannot be completely ruled out.
Second, in recent studies involving individuals with various diseases, index event bias (or collider-stratification bias) has been suggested as an explanation for the seemingly paradoxical associations. 4, [24] [25] [26] This study included healthy individuals without evident cardiovascular diseases [24] [25] [26] and adjusted for most major risk factors for vascular disease 4 ; thus, the observed associations are unlikely to be the result of this type of selection bias. When further analysis that included . Sex-and age-adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group. Eight categories of SBP (reference, 90-99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. A different y-axis scale was used for all-cause mortality and vascular mortality. CI indicates confidence interval. Third, a wide pulse pressure, rather than a low DBP, has been suggested as 1 possible explanation for the J-curve associations. 27 Because our study analyzed the SBP, where the wide pulse pressure hypothesis is irrelevant, and the associations with low SBP were maintained after additional adjustment for pulse pressure in the current study, and in previous research, as well, 2,5 a wide pulse pressure cannot explain the J-curve associations between SBP and vascular mortality.
The findings of a strong association of low SBP with death from ischemic heart disease and a weak association with death from stroke are consistent with the results of previous research conducted on individuals with vascular disease, 2,4-6 and on the nonclinical populations, as well. 13, 14 However, the association observed between low SBP and stroke mortality, for example, the inverse association of SBP <100 mm Hg in people aged 60 to 95 years, may conflict with the results of previous research. 2, 4, 6 This inconsistency may be mainly attributable to the differences in the subtype of stroke common to Korean populations versus European populations. According to Korean national mortality statistics, hemorrhagic stroke was a leading subtype of stroke mortality up until 2001. In younger populations (eg, those <70 years), the same is true in the present day. Of our participants, more individuals died of hemorrhagic stroke (n=6112) than of ischemic stroke (n=5623). In contrast, ischemic stroke accounts for the majority of strokes in populations of European origin. 28, 29 In the current study, the HR associated with an SBP <90 mm Hg was 1.65 (95% CI, 0.74-3.69) for mortality from hemorrhagic stroke, but was 0.75 (95% CI, 0.30-1.88) for ischemic stroke mortality in all participants. In the range <100 mm Hg, each 10 mm Hg increase in SBP was inversely associated with mortality from hemorrhagic stroke (HR, 0.53; 95% CI, 0.29-0.96), but not from ischemic stroke (HR, 1.00; 95% CI, 0.51-1.97).
In addition, the positive association of SBP <90 mm Hg with vascular mortality in comparison with the reference group, and the inverse associations of SBP with vascular mortality in the range <100 mm Hg, were statistically significant in participants aged 60 to 95 years, but not in their younger counterparts, in accordance with previous results. 4, 13, 14 However, it cannot be stated conclusively that the association in the range <100 mm Hg in people aged 30 to 59 years was different from that in people aged 60 to 95 years, especially for ischemic heart disease mortality, because the P values for the interaction between age and SBP were >0.05.
Association of Low DBP and Low Pulse Pressure With Vascular Mortality
In the general population, the associations of DBP and pulse pressure with vascular mortality have been shown to be weaker than the associations of SBP with vascular mortality. 1, 15, 16 In an additional analysis of our data, there was some evidence to suggest J-curve associations between DBP and atherosclerotic vascular mortality. However, the J-curve associations of DBP per se were weaker than those of SBP, in contrast to several studies on patients with manifest cardiovascular diseases, 2,4 and the associations disappeared or were substantially weakened after adjustment for SBP (Figures XIII through XV in the online-only Data Supplement). Pulse pressure seemed to have no apparent J-curve association with atherosclerotic vascular mortality (Figures XVI and XVII in the online-only Data Supplement).
Potential Mechanisms
An SBP <90 mm Hg may lead to hypoperfusion of the coronary arteries and thus cause cardiac events that then result in death from ischemic heart disease. In cases of ischemic stroke, although a low SBP (<90 mm Hg) may cause a reduction in cognitive performance, 30 it may not be sufficiently low to cause ischemic brain injury because a mean atrial pressure >45 to 50 mm Hg may be sufficient for brain survival. 31 For a hemorrhagic stroke, resulting from the mass effect from hematoma expansion and perihemorrhagic edema, an elevated intracranial pressure can increase the intracranial venous pressure. 32, 33 A low SBP that cannot compensate for the increase in venous pressure may result in insufficient perfusion of the brain tissue and subsequent death. 32 Furthermore, systolic hypotension <90 mm Hg is well known to be a poor prognostic factor in patients with traumatic brain injury, which can also cause intracranial hemorrhage. 34 Meanwhile, the mechanisms through which low SBP may cause hemorrhagic stroke are currently unclear. 
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Strengths and Limitations of This Study
The strengths of this study include its prospective design, a large number of participants, long-term duration, complete follow-up, and a homogeneous ethnic group. It also has several limitations. First, the procedure with which BP measurements were taken for the current study may not be ideal; there are higher published standards for BP research. 35 However, because the potential errors in the BP measurements are mostly likely to be random according to vascular mortality, 36, 37 overestimation of the relative risk associated with a low SBP is unlikely to be a major concern. Second, BP was measured only once. Thus, the relative risks associated with SBP may be underestimated in the current study because of a regression dilution bias. 38 Third, the causes of death were not verified independent from national death records. However, in Korea, cause of death on the death certificate was reported to be reasonably valid in comparison with medical records. 20 In addition, because potential misclassification tends not to depend on SBP, this issue is unlikely to cause an overestimation of the risk associated with low SBP. 39 Fourth, despite the large number of participants, the number of cause-specific vascular deaths in those with the lowest SBP was small, which may result in a decreased statistical power in some of the analyses. Fifth, given the observational nature of the study, definite causal inference is limited. In addition, although persons with self-reported hypertension, heart disease, stroke, cancer, liver disease, or respiratory disease were excluded from the study, lack of information on several potential confounders such as Multivariable adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group according to age. Eight categories of SBP (reference, 90-99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. No death was observed from ischemic stroke in persons aged 30 to 59 years with SBP 60 to 89 mm Hg. A different y-axis scale was used for all-cause mortality and vascular mortality. The numeric version of this figure is available in 
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BP medication use, and detailed cardiovascular and other disease status, is another limitation. Finally, the generalizability of the findings to the global population may be limited because all participants were Korean. Further research is thus needed to confirm whether this J-curve association exists among other ethnic groups. It is also worth mentioning that our study population is healthier and has a higher socioeconomic status (employees of the government or schools, or their dependents) than the general population in Korea. 17 We do not, however, think that the expected low death rate of a healthier population substantially impacts the association between SBP and vascular mortality.
Conclusion
In healthy Korean adults, a J-curve association exists between SBP and all-cause and vascular mortality. In persons with SBP >100 mm Hg, increases in SBP increase vascular mortality, whereas in persons with SBP <90 mm Hg, decreases in SBP are associated with higher vascular mortality, especially mortality from ischemic heart disease. Death from hemorrhagic stroke may also be associated with low SBP. Therefore, individuals with low SBPs should be clinically followed. Further research is required to confirm this association in other ethnic/ regional populations. Supplemental Figure 3 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group in all participants (graphical version of Table 2 ) and survivors after 5 years of follow-up.
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index.
Supplemental Figure 4. Diastolic blood pressure (DBP) and multi-variable adjusted hazard ratios for allcause and vascular mortality by systolic blood pressure (SBP) group in all participants (to examine whether the associations were independent of DBP).
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. In Model 1, adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, body mass index, and restricted cubic splines of DBP with five knots (50, 60, 70, 80, 90 mmHg). In Model 2, all covariables used in Model 1 were included, while continuous confounders (age, total cholesterol, fasting glucose, and body mass index) were included as cubic splines with three knots (5 th , 50 th , and 95 th percentiles).
Any cause Atherosclerotic vascular diseases
Ischemic heart diseases Total stroke
Ischemic stroke Hemorrhagic stroke
Supplemental Figure 5 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) and 90 mmHg as a reference in participants aged 60-95 years.
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term with the model with both the linear and the cubic spline terms. Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both the linear and the cubic spline terms. Adjustment was made for age at entry, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both the linear and the cubic spline terms. Adjustment was made for age at entry, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both the linear and the cubic spline terms. Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. In survivors as of January 1, 2003 (follow-up during 2003-2012), adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. In the sensitivity model among all-participants, co-variables that may cause non-proportional hazards over the follow-up time (violation of proportional hazard assumption) were stratified, while for several dummy variables of SBP with potential violations of assumption, time-dependent co-variables (which were generated using Model Statement of PROC PHREG procedure) were introduced in order to address non-proportionality. In the sensitivity model, analysis (PROC PHREG) stratified by age (years; <35, 35-44, 45-54, 55-64, 65-74, 75-84, ≥85), sex, exercise, alcohol intake (g/day; 0, 1-20, >20), total cholesterol (mg/dL; <200, 200-239, ≥240), and BMI (kg/m2; <18.5, 18.5-22.9, 23.0-24.9, ≥ 25.0), was done after adjustment for age, fasting glucose (mg/dL, continuous), smoking status, and several time-dependent dummy SBP co-variables (mmHg; 110-119, 120-139, 160-179, and ≥180). Figure 11 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group in all study participants and in individuals with known diseases (excluded in the main analysis, n=49,483) combined (Sensitivity analysis, collider stratification bias).
Supplemental
Supplemental Figure 12 . Multi-variable adjusted hazard ratios for all-cause and atherosclerotic vascular mortality by systolic blood pressure (SBP) group in individuals with known cardiovascular diseases (hypertension, heart diseases, or stroke; excluded in the main analysis; n=15,277) (Sensitivity analysis).
Supplemental Figure 13 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by diastolic blood pressure (DBP) group in all participants (to examine whether the associations were independent of SBP).
Eight categories of DBP (mmHg; <50, 50-59, 60-69 [reference], 70-79, 80-89, 90-99, 100-109, ≥110) were used. The midpoint was used as a representative value for each DBP category, except for both ends (41 and 114), for which the average of all participants was used. In the Main model, adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. In the Main model +SBP, additional adjustment was made for restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) .
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Supplemental Figure 14 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by restricted cubic splines of diastolic blood pressure (DBP) with five knots (50, 60, 70, 80, and 90 mmHg) and 60 mmHg as a reference.
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term with the model with both the linear and the cubic spline terms. Figure 15 . Systolic blood pressure and multi-variable adjusted hazard ratios for all-cause and vascular mortality by restricted cubic splines of diastolic blood pressure (DBP) with five knots (50, 60, 70, 80, and 90 mmHg) and 60 mmHg as a reference.
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, body mass index, and restricted cubic splines of systolic blood pressure with five knots (80, 90, 100, 110, and 120 mmHg). P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to that with both the linear and the cubic spline terms. Seven categories of PP (mmHg; <30, 30-39 [reference], 40-49, 50-59, 60-69, 70-79, ≥80) were used. The midpoint was used as a representative value for each PP category, except for both ends (21 and 86), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index.
Any cause Atherosclerotic vascular diseases
Ischemic stroke Hemorrhagic stroke
Supplemental Figure 17 . Multi-variable adjusted hazard ratios for all-cause and vascular mortality by restricted cubic splines of pulse pressure (PP) with five knots (20, 30, 40, 50, and 60 mmHg) and 40 mmHg as a reference.
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both the linear and the cubic spline terms. 1 Evidence from previous research suggests that low BP is a predictor of mortality in various clinical settings, and J-or U-curve associations between BP and vascular mortality have been reported among the elderly and those with vascular or other diseases. [2] [3] [4] [5] [6] [7] [8] [9] Low BP, even a single incidence of isolated hypotensive BP in certain situations, can predict mortality, 10 but despite the evidence, physicians often ignore low BP. 10, 11 There is no doubt, however, that a J-curve association between BP and mortality exists, even in the general population with no known comorbid diseases, because adequate perfusion to vital organs is difficult to sustain below a certain BP. In nonclinical populations, a few studies have found that low BP was associated with a higher mortality from vascular disease. [12] [13] [14] However, it is unclear whether and in what range of BP a J-curve occurs. We conducted a large prospective cohort study with >1 million participants to demonstrate whether a J-curve association exists between systolic BP (SBP) and mortality from vascular disease in a nonclinical population. We focused on SBP, because SBP has been shown to be a better predictor of mortality from vascular disease than diastolic BP (DBP) or pulse pressure in prospective studies among the general population.
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Methods
Study Participants
The (a former branch of the National Health Insurance Service) between 1992 and 1995. [17] [18] [19] For participants who underwent ≥2 examinations, data from the first examination were used. Approximately 96% of South Koreans are covered by the National Health Insurance Service, through which all Korean citizens are eligible to participate in regular health examinations. Six hundred ninety-six individuals who died during the year of enrollment were dropped from the sample. Other participants that were excluded consisted of 43 411 individuals whose records were missing information on body mass index (BMI), alcohol intake, blood pressure, fasting blood glucose levels, or total cholesterol levels; 49 483 persons who self-reported having cancer, liver disease, cardiovascular diseases (hypertension, heart disease, or stroke), or a respiratory disease at or before the baseline survey; and 689 persons with an extremely low BMI (<15.0 kg/m 2 ) or an extremely short stature (≤1.3 m). Thus, 1 235 246 individuals (445 239 women) were finally included in the study. The institutional review boards of Yonsei University and the Johns Hopkins University Bloomberg School of Public Health approved the study.
Data Collection
All participants underwent medical examinations at local hospitals. A standard mercury sphygmomanometer was used to measure BP in a seated position, and the SBP and DBP were measured as the first and fifth Korotkoff sounds, respectively. Total cholesterol and glucose levels were assayed from a fasting serum specimen, and each participating hospital in the examination had external quality control procedures that were supervised by the Korean Association of Laboratory Quality Control. The status of cigarette smoking (never, former, current), alcohol intake (grams of ethanol per day), and current participation in physical exercise (yes or no) were also collected by using self-reported questionnaires. Height and weight were measured while the participants wore light clothing without shoes, and BMI was calculated as weight in kilograms divided by height in meters squared (kg/m 2 ).
Follow-Up and Outcomes
Mortality of participants from 1993 through December 31, 2012 was confirmed with death records from the National Statistical Office of Korea. 20 The follow-up was performed through record linkage at the national level and was complete. The main outcomes for this study were death from atherosclerotic vascular diseases (I10-I15 [hypertensive diseases], I20-I25, I44-I52, I60-I69, I70-I74 [diseases Table I in the online-only Data Supplement. Cox proportional hazards models were used to evaluate the association between SBP at baseline and mortality, and the analyses were adjusted for the following covariates: age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/d; 0, 1-20, >20); physical activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m 2 ; continuous). The HRs of restricted cubic spline transformation of continuous confounders with 3 knots (5th, 50th, and 95th percentiles) with death from atherosclerotic vascular disease were plotted ( Figure I in the online-only Data Supplement). DBP was adjusted for as a continuous variable by using restricted cubic splines with 5 knots (50, 60, 70, 80, and 90 mm Hg) to examine whether the effects of SBP are independent of those of DBP. HRs of restricted cubic spline transformation of SBP with 5 knots (80, 90, 100, 110, and 120 mm Hg) and 90 mm Hg as a reference were also plotted. The nonlinear associations of SBP with vascular mortality were assessed with a likelihood ratio test, in which we compared the model with only the linear term with the model with both the linear and the cubic spline terms.
Statistical Analysis
Results
A total of 154 882 deaths (crude death rate, 683 deaths per 100 000 person-years) occurred during 22 674 299 personyears (mean, 18.4 person-years) of follow-up, and of these, 34 816 died of atherosclerotic vascular diseases (154 deaths per 100 000 person-years). At enrollment, the mean (standard deviation) age was 46.6 (11.6) years, and the mean SBP was 123.4 (17.2) mm Hg (Table 1) . Participants with SBP <90 mm Hg tended to be women and had the lowest levels of DBP, total cholesterol, fasting glucose, and BMI of all SBP groups. They were also older than those with SBPs of 90 to 139 mm Hg (Table II in Both low and high SBPs were associated with higher atherosclerotic vascular mortality (Figures 1 and 2) , and the lowest atherosclerotic vascular mortality was associated with an SBP of 90 to 109 mm Hg, which rose thereafter as the SBP increased; the mortality was also higher in those with an SBP <90 mm Hg (hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.15-2.03; Table 2 ). The HR associated with an SBP below 90 mm Hg, in comparison with 90 to 99 mm Hg, was 2.54 (95% CI, 1.51-4.29) for ischemic heart disease, and 1.21 (95% CI, 0.79-1.86) for stroke. Among stroke subtypes, the HR associated with an SBP <90 mm Hg was 1.64 for hemorrhagic stroke mortality and 0.76 for ischemic stroke mortality.
When stratified by age group, higher HRs associated with the lowest SBP for atherosclerotic vascular mortality and ischemic heart disease in comparison with the reference were statistically significant in older participants aged 60 to 95 years, but not in younger participants aged 30 to 59 years ( Figure 3 Table V in the online-only Data Supplement). However, when interactions between age and SBP were evaluated by using interaction terms of age and SBP, the P value was >0.05 for each type of vascular mortality given an SBP <100 mm Hg. In individuals aged 60 to 95 years, and in those aged 30 to 59 years, as well, vascular mortality increased as SBP increased to >90 to 99 mm Hg, and the association between high SBP and vascular mortality was greater among individuals <60 years than it was among those aged 60 to 95 years. The P values for the linear interaction between age and SBP were <0.001 for vascular mortality given an SBP of 100 to 290 mm Hg.
In analyses stratified by sex, the HRs associated with the lowest SBP for atherosclerotic vascular diseases were 1.63 (95% CI, 1.13-2.34) in women and 1.37 (95% CI, 0.87-2.14) in men (Figures VII through IX in the online-only Data Supplement, Table VII in the online-only Data Supplement). However, P values of linear interaction between men and women in the range <100 mm Hg were generally >0.05 (Table  VI in the online-only Data Supplement).
We tested the proportional assumption and found no evidence of a violation of the proportional assumption for the dummy variable of SBP <90 mm Hg for any cause of vascular mortality. However, evidence indicated that several variables including several dummy SBP variables may have nonproportional HRs over the follow-up time period. For such variables, analysis was done by stratifying according to the variables (not dummy SBP variables such as alcohol consumption and exercise). In addition, time-dependent covariables for dummy SBP variables (which were generated using the Model Statement of the PROC PHREG procedure) were included to address nonproportionality. 22 In addition, we analyzed individuals who survived as of January 1, 2003 
Discussion
Association Between Low SBP and Vascular Mortality
Second, in recent studies involving individuals with various diseases, index event bias (or collider-stratification bias) has been suggested as an explanation for the seemingly paradoxical associations. 4, [24] [25] [26] This study included healthy individuals without evident cardiovascular diseases [24] [25] [26] and adjusted for most major risk factors for vascular disease 4 ; thus, the observed associations are unlikely to be the result of this type of selection bias. When further analysis that included . Sex-and age-adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group. Eight categories of SBP (reference, 90-99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. A different y-axis scale was used for all-cause mortality and vascular mortality. CI indicates confidence interval.
Potential Mechanisms
Strengths and Limitations of This Study
The strengths of this study include its prospective design, a large number of participants, long-term duration, complete follow-up, and a homogeneous ethnic group. It also has several limitations. First, the procedure with which BP measurements were taken for the current study may not be ideal; there are higher published standards for BP research. 35 However, because the potential errors in the BP measurements are mostly likely to be random according to vascular mortality, 36, 37 overestimation of the relative risk associated with a low SBP is unlikely to be a major concern. Second, BP was measured only once. Thus, the relative risks associated with SBP may be underestimated in the current study because of a regression dilution bias. 38 Third, the causes of death were not verified independent from national death records. However, in Korea, cause of death on the death certificate was reported to be reasonably valid in comparison with medical records. 20 In addition, because potential misclassification tends not to depend on SBP, this issue is unlikely to cause an overestimation of the risk associated with low SBP. 39 Fourth, despite the large number of participants, the number of cause-specific vascular deaths in those with the lowest SBP was small, which may result in a decreased statistical power in some of the analyses. Fifth, given the observational nature of the study, definite causal inference is limited. In addition, although persons with self-reported hypertension, heart disease, stroke, cancer, liver disease, or respiratory disease were excluded from the study, lack of information on several potential confounders such as Figure 3 . Multivariable adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group according to age. Eight categories of SBP (reference, 90-99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. No death was observed from ischemic stroke in persons aged 30 to 59 years with SBP 60 to 89 mm Hg. A different y-axis scale was used for all-cause mortality and vascular mortality. The numeric version of this figure is available in Table III in the online-only Data Supplement. CI indicates confidence interval.
Conclusion
In healthy Korean adults, a J-curve association exists between SBP and all-cause and vascular mortality. In persons with SBP >100 mm Hg, increases in SBP increase vascular mortality, whereas in persons with SBP <90 mm Hg, decreases in SBP are associated with higher vascular mortality, especially mortality from ischemic heart disease. Death from hemorrhagic stroke may also be associated with low SBP. Therefore, individuals with low SBPs should be clinically followed. Further research is required to confirm this association in other ethnic/ regional populations.
